Evolent Health (EVH) Cash & Current Investments (2015 - 2026)

Evolent Health has reported Cash & Current Investments for 12 years, with the latest figure at $141.5 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 20.51% year-over-year to $141.5 million in Q2 2026; TTM through Jun 2026 was $141.5 million, a 20.51% decrease from a year earlier, with the FY2025 full-year figure at $180.7 million, up 1.23% from the prior year.
• Cash & Current Investments was $141.5 million for Q2 2026 at Evolent Health, down from $168.7 million in the prior quarter.
• The five-year high for Cash & Current Investments was $280.4 million in Q2 2022, with the low at $127.9 million in Q3 2024.
• Average Cash & Current Investments over 5 years is $198.2 million, with a median of $193.4 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments slumped 43.05% in 2024, then rose 29.01% in 2025.
• Over 5 years, Cash & Current Investments stood at $215.2 million in 2022, then advanced by 3.86% to $223.5 million in 2023, then slipped by 20.12% to $178.5 million in 2024, then advanced by 1.23% to $180.7 million in 2025, then declined by 21.71% to $141.5 million in 2026.
• The last three Cash & Current Investments figures came in at $141.5 million (Q2 2026), $168.7 million (Q1 2026), and $180.7 million (Q4 2025), per Business Quant data.